Clinico-Molecular Risk Stratification in 284 Patients With Pre-Fibrotic and Overt Myelofibrosis

被引：0
|
作者：
Chang, Yu-Sung [1 ]
Wang, Yu-Hung [1 ,2 ]
Wei, Chao-Hung [3 ,4 ]
Lin, Chien-Chin [1 ,5 ]
Yuan, Chang-Tsu [6 ]
Tsai, Cheng-Hong [1 ,7 ]
Liu, Jia-Hau [8 ]
Ko, Bor-Sheng [8 ]
Yao, Ming [8 ]
Tien, Hwei-Fang [1 ,9 ]
Chou, Wen-Chien [1 ,5 ]
Hou, Hsin-An [1 ,10 ]
机构：
[1] Natl Taiwan Univ Hosp, Div Hematol, Dept Internal Med, Taipei, Taiwan
[2] Univ Manchester, Div Canc Sci, Epigenet Haematopoiesis Lab, Manchester, England
[3] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[6] Natl Taiwan Univ, Dept Pathol, Canc Ctr, Taipei, Taiwan
[7] Natl Taiwan Univ Hosp, Dept Med Educ & Res, Yunlin Branch, Touliu, Yunlin, Taiwan
[8] Natl Taiwan Univ, Canc Ctr, Dept Hematol Oncol, Taipei, Taiwan
[9] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan
[10] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
MPN; myelofibrosis; genetic mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-239
引用
收藏
页码：S424 / S424
页数：1
相关论文
共 50 条
  • [31] Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts
    Mynarek, Martin
    Obrecht, Denise
    Sill, Martin
    Sturm, Dominik
    Kloth-Stachnau, Katja
    Selt, Florian
    Ecker, Jonas
    von Hoff, Katja
    Juhnke, Bjoern-Ole
    Goschzik, Tobias
    Pietsch, Torsten
    Bockmayr, Michael
    Kool, Marcel
    von Deimling, Andreas
    Witt, Olaf
    Schuller, Ulrich
    Benesch, Martin
    Gerber, Nicolas U.
    Sahm, Felix
    Jones, David T. W.
    Korshunov, Andrey
    Pfister, Stefan M.
    Rutkowski, Stefan
    Milde, Till
    ACTA NEUROPATHOLOGICA, 2023, 145 (01) : 97 - 112
  • [32] Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts
    Martin Mynarek
    Denise Obrecht
    Martin Sill
    Dominik Sturm
    Katja Kloth-Stachnau
    Florian Selt
    Jonas Ecker
    Katja von Hoff
    Björn-Ole Juhnke
    Tobias Goschzik
    Torsten Pietsch
    Michael Bockmayr
    Marcel Kool
    Andreas von Deimling
    Olaf Witt
    Ulrich Schüller
    Martin Benesch
    Nicolas U. Gerber
    Felix Sahm
    David T. W. Jones
    Andrey Korshunov
    Stefan M. Pfister
    Stefan Rutkowski
    Till Milde
    Acta Neuropathologica, 2023, 145 : 97 - 112
  • [33] Prospective Evaluation of a Prognostic Clinico-Molecular Score (DEMo) to Predict Outcome of Advanced NSCLC Patients Treated with Immunotherapy
    Prelaj, A.
    Proto, C.
    Lo Russo, G.
    Signorelli, D.
    Ferrara, R.
    Mensah, M.
    Galli, G.
    De Toma, A.
    Randon, G.
    Pagani, F.
    Brambilla, M.
    Trevisan, B.
    Ganzinelli, M.
    Zilembo, N.
    De Braud, F.
    Torri, V.
    Garassino, M.
    Sozzi, G.
    Boeri, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S259 - S260
  • [34] Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS
    Michaud, Vincent
    Lasseaux, Eulalie
    Plaisant, Claudio
    Verloes, Alain
    Perdomo-Trujillo, Yaumara
    Hamel, Christian
    Elcioglu, Nursel H.
    Leroy, Bart
    Kaplan, Josseline
    Jouk, Pierre-Simon
    Lacombe, Didier
    Fergelot, Patricia
    Morice-Picard, Fanny
    Arveiler, Benoit
    PIGMENT CELL & MELANOMA RESEARCH, 2017, 30 (06) : 563 - 570
  • [35] Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome
    Benites, Bruno Deltreggia
    Costa Lima, Carolina Silva
    Lorand-Metze, Irene
    Delamain, Marcia Torresan
    Oliveira, Gislaine Borba
    de Almeida, Daiane
    de Souza, Carmino Antonio
    Vassallo, Jose
    Barbosa Pagnano, Katia Borgia
    CLINICS, 2013, 68 (03) : 339 - 343
  • [36] Clinico-molecular characteristics of Chinese primary non-small cell lung cancer patients with compound EGFR mutations
    Duan, J.
    Bai, H.
    Wang, X.
    Wan, R.
    Cheng, H.
    Wang, H.
    Lou, F.
    Cao, S.
    Wang, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients
    Tefferi, Ayalew
    Wassie, Emnet A.
    Begna, Kebede
    Finke, Christy
    Belachew, Alem A.
    Gangat, Naseema
    Lasho, Terra L.
    Pardanani, Animesh
    Hanson, Curtis A.
    Ketterling, Rhett
    BLOOD, 2014, 124 (21)
  • [38] Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients
    Tefferi, Ayalew
    Nicolosi, Maura
    Mudireddy, Mythri
    Lasho, Terra L.
    Gangat, Naseema
    Begna, Kebede H.
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Pardanani, Animesh
    LEUKEMIA, 2018, 32 (05) : 1189 - 1199
  • [39] Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients
    Ayalew Tefferi
    Maura Nicolosi
    Mythri Mudireddy
    Terra L. Lasho
    Naseema Gangat
    Kebede H. Begna
    Curtis A. Hanson
    Rhett P. Ketterling
    Animesh Pardanani
    Leukemia, 2018, 32 : 1189 - 1199
  • [40] Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis
    Lucijanic, Marko
    Krecak, Ivan
    Galusic, Davor
    Holik, Hrvoje
    Perisa, Vlatka
    Peric, Martina Moric
    Zekanovic, Ivan
    Budimir, Josipa
    Lekovic, Danijela
    Kusec, Rajko
    ANNALS OF HEMATOLOGY, 2024, 103 (06) : 2157 - 2159
12345